Managing Hypotension During CVVHD
The primary approach to hypotension during continuous venovenous hemodialysis (CVVHD) is to slow or temporarily stop ultrafiltration while maintaining blood flow, as CVVHD inherently provides superior hemodynamic stability compared to intermittent hemodialysis, making aggressive fluid removal the most common culprit.
Why CVVHD Patients Develop Hypotension
The continuous nature of CVVHD typically prevents the dramatic blood pressure swings seen with intermittent hemodialysis. However, hypotension still occurs when:
- Ultrafiltration rate exceeds vascular refilling capacity - Even at slower rates, critically ill patients may have impaired compensatory mechanisms
- Underlying cardiac dysfunction - Heart failure patients cannot augment cardiac output appropriately 1
- Sepsis or distributive shock - Vasodilation overwhelms volume management
- Excessive target fluid removal - Overly aggressive dry weight goals
Immediate Management Algorithm
Step 1: Adjust Ultrafiltration First
- Reduce ultrafiltration rate by 50% or temporarily stop UF while maintaining blood flow at 100-150 mL/min 2, 3
- This allows continued solute clearance (urea clearance ~15-27 mL/min) without further volume depletion 2, 3
- Do NOT stop the entire CVVHD circuit - the blood pump can continue at standard rates (120-200 mL/min) 1, 3
Step 2: Reassess Volume Status
- Review total fluid balance over the past 24 hours
- Check for signs of hypovolemia: decreased CVP, poor skin turgor, dry mucous membranes
- Consider that the prescribed dry weight may be too aggressive - look for improving nutrition markers (rising albumin, creatinine) coinciding with hypotension 4
Step 3: Modify CVVHD Prescription
If hypotension recurs:
Ultrafiltration modifications:
- Decrease hourly UF target (aim for <100-200 mL/hour initially) 5
- Extend treatment time to achieve fluid goals more gradually
- Consider isolated ultrafiltration periods separated from dialysis 4
Dialysate modifications:
- Increase dialysate sodium concentration to 148 mEq/L - this is highly effective for preventing hypotension 4
- Use bicarbonate-buffered dialysate if acetate is being used (acetate causes inappropriate vasodilation) 4
- Reduce dialysate temperature to 34-35°C - increases peripheral vasoconstriction and improves cardiac output 4, 6, 4
Step 4: Pharmacologic Support
When prescription modifications are insufficient:
- Midodrine 5-12.5 mg orally pre-dialysis (if patient can take oral medications) 4
- Vasopressors (norepinephrine preferred) for distributive shock
- Correct anemia to target hemoglobin per guidelines 4
- Consider supplemental oxygen 4
Key Advantages of CVVHD for Hypotension-Prone Patients
CVVHD offers superior hemodynamic stability compared to intermittent hemodialysis 7, 2, 1:
- Gradual, controlled fluid removal prevents rapid intravascular volume depletion
- Studies show excellent cardiovascular stability even in critically ill patients with multiple organ failure 2, 3
- Allows adequate parenteral nutrition without fluid overload concerns 5
- Maintains stable blood pressure even in patients with severe heart failure who cannot tolerate intermittent dialysis 1
Critical Pitfalls to Avoid
Do not decrease blood flow rate in response to hypotension - this compromises clearance without addressing the underlying problem 4
Do not give saline boluses reflexively - this defeats the purpose of ultrafiltration and perpetuates volume overload 8
Do not use low-calcium dialysate (≤2.5 mEq/L) - this decreases cardiac contractility and worsens hypotension 6
Do not assume hypotension means the patient is at dry weight - hypotension cannot be used to define intravascular volume 4
Avoid stopping CVVHD entirely - the continuous nature is precisely what provides stability; instead modify the UF rate 2, 5
When CVVHD May Not Be Appropriate
If hypotension remains refractory despite these interventions, consider:
- Underlying cardiac tamponade, massive PE, or other mechanical causes
- Severe distributive shock requiring high-dose vasopressors
- Whether the patient needs transition to peritoneal dialysis for better hemodynamic tolerance 9
The evidence consistently shows CVVHD provides outstanding metabolic control with minimal hemodynamic compromise when properly managed 2, 1, 3, 5.